-
Alzheimer’s: First drug to slow progression of disease gains approval of US regulator the FDA | Science & Tech News
admin
The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzheimer’s disease for the first time. The FDA has granted full regulatory approval to Leqembi – a drug by Japanese manufacturers Eisai and US drugmakers Biogen. Up to now, other approved drugs targeted only the symptoms of the…
-
‘Historic moment’ in Alzheimer’s treatment as trial drug found to slow cognitive decline | Science & Tech News
admin
A new drug found to reduce cognitive decline in early-stage Alzheimer’s has been hailed as an “historic moment” in the treatment of the disease. During trials, Lecanemab was found to slow the decline in people’s memory and thinking by up to 27% over 18 months, compared with a placebo. Alzheimer’s Research UK called the finding…